How to determine an impaired health status in COPD: Results from a population-based study

Netherlands Journal of Medicine

Volumn 75, Issue 4, 2017, Pages 151-157

  Smid, D E ^a   Spruit, M A ^a   Deeg, D J H ^b   Huisman, M ^b,c   Poppelaars, J ^b,c   Wouters, E F M ^a,d   Franssen, F M E ^a,d  

^a CIRO Center of Expertise for Chronic Organ Failure   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease (COPD); COPD assessment test; Health status; Normative values

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSESSMENT; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; GENERAL PRACTITIONER; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SPIROMETRY; WORK; CLASSIFICATION; LONGITUDINAL STUDY; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; REFERENCE VALUE; SEVERITY OF ILLNESS INDEX;

FEMALE; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 85019268548     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. AJRCCM. 2017.
2. Foo J, Landis SH, Maskell J, Oh YM, et al. Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries. PloS One. 2016;11:e0152618.
3. ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD. 2007;4:293-7.
4. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J. 2002;20:799-805.
5. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648-54.
6. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347-65.
7. Evans BJ, Stevenson SJ. The Pattern Glare Test: a review and determination of normative values. Ophthalmic Physiol Opt. 2008;28:295-309.
8. Echocardiographic Normal Ranges Meta-Analysis of the Left Heart C. Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function: The EchoNoRMAL Study. JACC Cardiovasc Imaging. 2015;8:656-65.
9. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:412.
10. Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42:647-54.
11. Woodruff PG, Barr RG, Bleecker E, et al. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med. 2016;374:1811-21.
12. Nishimura K, Mitsuma S, Kobayashi A, et al. COPD and disease-specific health status in a working population. Respir Res. 2013;14:61.
13. Pinto LM, Gupta N, Tan W, et al. Derivation of normative data for the COPD assessment test (CAT). Respir Res. 2014;15:68.
14. Jones PW, Shahrour N, Nejjari C, et al. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir Med. 2012;106 Suppl 2:S86-99.
15. Andenaes R, Bentsen SB, Hvinden K, Fagermoen MS, Lerdal A. The relationships of self-efficacy, physical activity, and paid work to health-related quality of life among patients with chronic obstructive pulmonary disease (COPD). J Multidiscip Healthc. 2014;7:239-47.
16. Huisman M, Poppelaars J, van der Horst M, et al. Cohort profile: the Longitudinal Aging Study Amsterdam. Int J Epidemiol. 2011;40:868-76.
17. Quanjer PH, Brazzale DJ, Boros PW, Pretto JJ. Implications of adopting the Global Lungs Initiative2012 all-age reference equations for spirometry. Eur Respir J. 2013;42:1046-54.
18. Kart L, Akkoyunlu ME, Bayram M, et al. COPD: an underdiagnosed disease at hospital environment. Wien Klin Wochenschr. 2014;126:73-8.
19. Office of the Surgeon General (US); Center for Mental Health Services (US); National Institute of Mental Health (US). Mental Health: Culture, Race, and Ethnicity: A Supplement to Mental Health: A Report of the Surgeon General. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2001 Aug. Chapter 2 Culture Counts: The Influence of Culture and Society on Mental Health. Available from: http://www.ncbi.nlm.nih.gov/books/NBK44249/.
20. Brewer G, Robinson S, Sumra A, Tatsi E, Gire N. The Influence of Religious Coping and Religious Social Support on Health Behaviour, Health Status and Health Attitudes in a British Christian Sample. J Relig Health. 2015;54:2225-34.
21. Negewo NA, McDonald VM, Gibson PG. Comorbidity in chronic obstructive pulmonary disease. Respir Investig. 2015;53:249-58.
22. Ferre A, Fuhrman C, Zureik M, et al. Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions. Respir Med. 2012;106:467-71.
23. Waschki B, Kirsten AM, Holz O, et al. Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015:192:295-306.
24. Casanova C, Marin JM, Martinez-Gonzalez C, et al. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD. Chest. 2015;148:159-68.
25. Al Moamary MS, Tamim HM, Al-Mutairi SS, et al. Quality of life of patients with chronic obstructive pulmonary disease in the Gulf Cooperation Council countries. Saudi Med J. 2012;33:1111-7.
26. Gupta N, Pinto L, Benedetti A, et al. The COPD Assessment Test: can it discriminate across COPD subpopulations? Chest. 2016;150:1069-79.
27. Miyazaki M, Nakamura H, Chubachi S, et al. Analysis of comorbid factors that increase the COPD assessment test scores. Respir Res. 2014;15:13.
28. Triest FJ, Franssen FM, Spruit MA, Groenen MT, Wouters EF, Vanfleteren LE. Poor agreement between chart-based and objectively identified comorbidities of COPD. Eur Respir J. 2015;46:1492-5.
29. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187:728-35.